• Issue

    Clinical and Experimental Neuroimmunology: Volume 13, Issue 3

    i-iii, 131-189
    August 2022

ISSUE INFORMATION

Free Access

Issue Information

  • Pages: i-iii
  • First Published: 30 August 2022

EDITORIAL

Monoclonal antibody treatment for multiple sclerosis and neuromyelitis optica spectrum disorder: An update

  • Pages: 131-132
  • First Published: 30 August 2022

FOCUSED REVIEW SERIES ON MONOCLONAL ANTIBODY DRUGS: UP TO DATE IN MULTIPLE SCLEROSIS AND NEUROMYELITIS OPTICA SPECTRUM DISORDER

MS/NMO AND ALLIED DISORDER

ORIGINAL ARTICLE

Radiological characteristics of neuromyelitis optica spectrum disorder in Egypt

  • Pages: 172-181
  • First Published: 10 February 2022
Radiological characteristics of neuromyelitis optica spectrum disorder in Egypt

Magnetic resonance imaging (MRI) plays an important role in the diagnosis of NMOSD based on the 2015 consensus criteria and its differentiation from other mimickers. High frequency of abnormal Spine and Brain MRI findings was found in Egyptian population. Even though no specific patterns were typical for AQP4-seropositive patients, certain findings may suggest NMOSD diagnosis and warrant AQP4-IgGs testing.

GBS/CIDP AND ALLIED DISORDERS

ORIGINAL ARTICLE

Demyelinating neuropathy requires differential diagnosis with vasculitic neuropathy in rheumatoid arthritis: Significance of sural nerve electrophysiology findings

  • Pages: 182-189
  • First Published: 18 February 2022
Demyelinating neuropathy requires differential diagnosis with vasculitic neuropathy in rheumatoid arthritis: Significance of sural nerve electrophysiology findings

Demyelinating neuropathy was found more often in patients with RA neuropathy than expected. Particular nerve conduction studies parameters are useful for the differential diagnosis of RA patients with neuropathy.